Doctors recommend continuous glucose monitoring for patients with type 1 diabetesBMJ 2016; 354 doi: https://doi.org/10.1136/bmj.i5247 (Published 27 September 2016) Cite this as: BMJ 2016;354:i5247
- Michael McCarthy
Adult patients with type 1 diabetes should use continuous glucose monitoring (CGM) devices to manage their blood glucose levels, the Endocrine Society has recommended in new guidelines.1
The recommendations, which were published in the society’s Journal of Clinical Endocrinology and Metabolism, were supported by the European Society of Endocrinology.
CGM devices, which use subcutaneous sensors to monitor blood glucose concentration, let patients track their blood glucose levels in near real time and adjust their insulin doses accordingly. The devices usually have alarms that warn patients when their blood glucose falls too low or rises …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial